Education
About Us
Working with TipRanks
Follow Us
Pfizer Inc (PFE)
:PFE
Earnings Data
Report Date
Nov 04, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.72Last Year’s EPS
1.06Same Quarter Last Year
Based on 17 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment overall, with Pfizer showing strong financial performance, significant advancements in its R&D pipeline, and effective cost management. However, there are some challenges, particularly related to pricing pressures from the IRA Medicare Part D redesign and competitive pressures in the oncology sector.Company Guidance
Strong Year-to-Date Performance and Raised EPS Guidance
Pfizer raised its adjusted diluted EPS guidance for the full year 2025 due to strong year-to-date performance, indicating confidence in its financial outlook.
Significant R&D Advancements
Pfizer highlighted several promising developments in its R&D pipeline, including Elrexfio's notable performance in multiple myeloma and Sigvotatug Vedotin's potential in non-small cell lung cancer.
Strong Growth in Key Products
The Vyndaqel family saw a 21% year-over-year operational growth, and Padcev experienced a 38% operational growth, demonstrating robust demand for key products.
Cost Management and Operating Margins
Pfizer's cost optimization strategies led to an 8% decline in total adjusted operating expenses, contributing to improved operating margins.
Strategic Business Development Initiatives
Pfizer closed an in-licensing agreement with 3SBio, granting exclusive rights to develop and commercialize a promising bispecific antibody.
PFE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PFE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 06, 2025 | $24.75 | $23.93 | -3.31% |
Apr 29, 2025 | $22.23 | $22.95 | +3.24% |
Feb 04, 2025 | $25.27 | $24.96 | -1.23% |
Oct 29, 2024 | $26.97 | $26.59 | -1.41% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Pfizer Inc (PFE) report earnings?
Pfizer Inc (PFE) is schdueled to report earning on Nov 04, 2025, Before Open (Confirmed).
What is Pfizer Inc (PFE) earnings time?
Pfizer Inc (PFE) earnings time is at Nov 04, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PFE EPS forecast?
PFE EPS forecast for the fiscal quarter 2025 (Q3) is 0.72.
